GUMDROP : NCI 11-C-0140 A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients With Advanced or Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors

Created by Marte, Jenn (NIH/NCI) [E], last modified by Nancy Dawson on Jun 02, 2013

Description:

Lenalidomide has not yet been approved for use in combination with gemcitabine and carboplatin. This phase I study will examine the safety and effectiveness of this combination in solid tumors, particularly urothelial cancer. Participants must be ineligible for cisplatin.

Link:

http://www.clinicaltrials.gov/ct2/show/NCT01352962

Site:

NCI

Principal Investigator:

Andrea Apolo